Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A case report
Rev. Soc. Bras. Med. Trop
;
54: e03852021, 2021.
Artículo
en Inglés
| LILACS
| ID: biblio-1347104
ABSTRACT
Abstract The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with inactivated viruses. Thus, this study aimed to report a case of passive anti-SARS-CoV-2 immunity in a newborn through immunoprophylaxis of a pregnant woman who received the CoronaVac® vaccine in the third trimester of pregnancy. Twenty-four hours after delivery, samples were collected from the newborn and screened by enzyme immunoassays, which revealed antibodies to SARS-CoV-2.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Complicaciones Infecciosas del Embarazo
/
Vacunas
/
COVID-19
Límite:
Femenino
/
Humanos
/
Recién Nacido
/
Embarazo
Idioma:
Inglés
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
Medicina Tropical
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Universidade do Estado de São Paulo/BR
/
Universidade do Sul de Santa Catarina/BR
Similares
MEDLINE
...
LILACS
LIS